OPHTHALMOLOGIC SAFETY PROFILE OF ANTIMALARIAL-DRUGS

被引:0
|
作者
RYNES, RI
BERNSTEIN, HN
机构
[1] WASHINGTON NATL EYE CTR,WASHINGTON,DC
[2] WASHINGTON HOSP CTR,DEPT OPHTHALMOL,WASHINGTON,DC 20010
关键词
ANTIMALARIALS; HYDROXYCHLOROQUINE; CHLOROQUINE; RETINOPATHY; OPHTHALMIC TOXICITY;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The ophthalmologic safety of antimalarial drugs is well established, but absolute safety cannot be assured. Three types of side effects may develop. Corneal deposits and neuromuscular-associated blurred vision are always reversible and therefore benign. Visual loss has occurred in patients with retinopathy. Retinopathy may be divided into true retinopathy and premaculopathy. It is true retinopathy that may be associated with visual loss, while premaculopathy consists of subtle visual field and funduscopic abnormalities. These premaculopathic changes are generally completely reversible with drug discontinuation and have not been shown to progress. Hydroxychloroquine appears safer than chloroquine when currently accepted equivalent doses are used. Fewer than 20 patients with true retinopathy caused by hydroxychloroquine have been reported; more patients have developed true retinopathy when taking chloroquine. The safety profile is most dependent on low daily dose and regular ophthalmologic monitoring. The optimal strategy of ophthalmologic testing has not yet been determined, but visual acuity, funduscopic examination and visual field examination should be monitored. Self-administered ophthalmologic testing with Amsler grids may contribute additional safety but is not a replacement for physician testing.
引用
收藏
页码:S17 / S19
页数:3
相关论文
共 50 条
  • [1] ANTIMALARIAL-DRUGS - AN UPDATE
    WARHURST, DC
    DRUGS, 1987, 33 (01) : 50 - 65
  • [2] TOXIDERMIA WITH ANTIMALARIAL-DRUGS
    GILLET, P
    GILLETTERVER, MN
    BANNWARTH, B
    TRECHOT, P
    PERE, P
    NETTER, P
    GAUCHER, A
    THERAPIE, 1991, 46 (05): : 391 - 391
  • [3] TOXICITY OF ANTIMALARIAL-DRUGS
    PETO, TEA
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1989, 82 : 30 - 33
  • [4] ANTIMALARIAL-DRUGS AND PREGNANCY
    PARKE, A
    AMERICAN JOURNAL OF MEDICINE, 1988, 85 (4A): : 30 - 33
  • [5] USE OF ANTIMALARIAL-DRUGS
    HANSFORD, CF
    SOUTH AFRICAN MEDICAL JOURNAL, 1974, 48 (30): : 1314 - 1316
  • [6] ANTIMALARIAL-DRUGS AND PREGNANCY
    BRICAIRE, F
    SALMON, D
    DANIS, M
    GENTILINI, M
    BULLETIN DE LA SOCIETE DE PATHOLOGIE EXOTIQUE, 1991, 84 (05): : 721 - 738
  • [7] PROCUREMENT AND DISTRIBUTION OF ANTIMALARIAL-DRUGS
    不详
    WHO TECHNICAL REPORT SERIES, 1990, (805) : 95 - 109
  • [8] RISKS AND BENEFITS OF ANTIMALARIAL-DRUGS
    FISH, DR
    ESPIR, MLE
    BRITISH MEDICAL JOURNAL, 1989, 299 (6714): : 1524 - 1524
  • [9] CURRENTLY IMPORTANT ANTIMALARIAL-DRUGS
    WINSTANLEY, PA
    BRECKENRIDGE, AM
    ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY, 1987, 81 (05): : 619 - 627
  • [10] POSSIBLE NEW ANTIMALARIAL-DRUGS
    PETERS, W
    NATURE, 1974, 249 (5455) : 305 - 306